Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA.
Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA
J Neurointerv Surg. 2022 Dec;14(12):1279-1283. doi: 10.1136/neurintsurg-2021-018073. Epub 2021 Dec 6.
Few reports discuss variables associated with improved outcomes after middle meningeal artery (MMA) embolization for chronic subdural hematomas (cSDHs). We analyzed radiographic evidence of cSDH clearance after MMA embolization to elucidate optimal techniques, hematoma clearance rates, and suitable length of follow-up.
Patients who underwent MMA embolization for cSDH from January 1, 2018 through December 31, 2020 were analyzed. Patient characteristics, demographics, and technical procedural details were examined. Outcomes for cSDHs analyzed included complete or near-complete resolution at 30, 90, and 180 days following embolization. A multivariable logistic regression analysis identified variables predictive of rapid clearance and resolution of hematomas at 90 days.
The study cohort comprised 66 patients with 84 treated cSDHs. The mean (SD) cSDH size differed significantly at 30-day (8.8 (4.3) mm), 90-day (3.4 (3.0) mm), and 180-day (1.0 (1.7) mm) follow-up (p<0.001). More cSDHs had complete or near-complete resolution at 180 days (92%, 67/73) than at 90 (63%, 45/72) and 30 days (18%, 15/84) post-embolization (p<0.001). Only distal embolysate penetration was independently associated with rapid clearance (OR 3.9, 95% CI 1.4 to 11.1; p=0.01) and resolution of cSDHs at 90 days (OR 5.0, 95% CI 1.7 to 14.6; p=0.003).
Although 63% of cSDHs with MMA embolization had complete or near-complete resolution by 90 days post-procedure, 92% reached this stage by 180 days. Therefore, 90-day follow-up may be insufficient to determine the effectiveness of MMA embolization for cSDHs, particularly compared with surgical evacuation alone. Also, distal MMA penetration may be associated with more rapid hematoma clearance.
很少有报道讨论与慢性硬脑膜下血肿(cSDH)患者经中脑膜动脉(MMA)栓塞治疗后改善结局相关的变量。我们分析了 MMA 栓塞治疗 cSDH 后的放射影像学血肿清除证据,以阐明最佳技术、血肿清除率和合适的随访时间。
分析了 2018 年 1 月 1 日至 2020 年 12 月 31 日期间接受 MMA 栓塞治疗的 cSDH 患者。检查了患者特征、人口统计学和技术操作细节。分析 cSDH 的结果包括栓塞后 30、90 和 180 天完全或近乎完全缓解。多变量逻辑回归分析确定了预测血肿在 90 天内快速清除和缓解的变量。
研究队列包括 66 例患者,84 例 cSDH 患者接受治疗。30 天(8.8(4.3)mm)、90 天(3.4(3.0)mm)和 180 天(1.0(1.7)mm)随访时 cSDH 大小差异有统计学意义(p<0.001)。180 天(92%,67/73)完全或近乎完全缓解的 cSDH 多于 90 天(63%,45/72)和 30 天(18%,15/84)(p<0.001)。只有远端栓塞剂渗透与血肿快速清除(优势比 3.9,95%置信区间 1.4 至 11.1;p=0.01)和 90 天 cSDH 缓解(优势比 5.0,95%置信区间 1.7 至 14.6;p=0.003)独立相关。
尽管 MMA 栓塞治疗的 63%的 cSDH 在术后 90 天达到完全或近乎完全缓解,但 92%在 180 天达到这一阶段。因此,与单独手术清除相比,90 天的随访可能不足以确定 MMA 栓塞治疗 cSDH 的效果。此外,MMA 远端穿透可能与血肿清除速度更快相关。